The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Colorectal Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Colorectal Neoplasms


Psychiatry related information on Colorectal Neoplasms


High impact information on Colorectal Neoplasms


Chemical compound and disease context of Colorectal Neoplasms


Biological context of Colorectal Neoplasms


Anatomical context of Colorectal Neoplasms


Gene context of Colorectal Neoplasms


Analytical, diagnostic and therapeutic context of Colorectal Neoplasms


  1. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. Kemeny, N., Huang, Y., Cohen, A.M., Shi, W., Conti, J.A., Brennan, M.F., Bertino, J.R., Turnbull, A.D., Sullivan, D., Stockman, J., Blumgart, L.H., Fong, Y. N. Engl. J. Med. (1999) [Pubmed]
  2. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Laken, S.J., Petersen, G.M., Gruber, S.B., Oddoux, C., Ostrer, H., Giardiello, F.M., Hamilton, S.R., Hampel, H., Markowitz, A., Klimstra, D., Jhanwar, S., Winawer, S., Offit, K., Luce, M.C., Kinzler, K.W., Vogelstein, B. Nat. Genet. (1997) [Pubmed]
  3. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. Wijnen, J.T., Vasen, H.F., Khan, P.M., Zwinderman, A.H., van der Klift, H., Mulder, A., Tops, C., Møller, P., Fodde, R. N. Engl. J. Med. (1998) [Pubmed]
  4. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Sterner-Kock, A., Thorey, I.S., Koli, K., Wempe, F., Otte, J., Bangsow, T., Kuhlmeier, K., Kirchner, T., Jin, S., Keski-Oja, J., von Melchner, H. Genes Dev. (2002) [Pubmed]
  5. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C., Kotchen, J.M., Ockene, J. JAMA (2002) [Pubmed]
  6. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. Qiu, Y., Patwa, T.H., Xu, L., Shedden, K., Misek, D.E., Tuck, M., Jin, G., Ruffin, M.T., Turgeon, D.K., Synal, S., Bresalier, R., Marcon, N., Brenner, D.E., Lubman, D.M. J. Proteome Res. (2008) [Pubmed]
  7. Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer. Haydon, A.M., Macinnis, R.J., English, D.R., Morris, H., Giles, G.G. Gut (2006) [Pubmed]
  8. Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer. Hong, Y.C., Lee, K.H., Kim, W.C., Choi, S.K., Woo, Z.H., Shin, S.K., Kim, H. Int. J. Cancer (2005) [Pubmed]
  9. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate. Crew, T.E., Elder, D.J., Paraskeva, C. Carcinogenesis (2000) [Pubmed]
  10. Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Glimelius, B. Ann. Oncol. (1993) [Pubmed]
  11. A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging. Moffat, F.L., Gulec, S.A., Serafini, A.N., Sfakianakis, G.N., Pop, R., Robinson, D.S., Franceschi, D., Boggs, J., Livingstone, A.S. Cancer Invest. (1999) [Pubmed]
  12. The use of cancer registry data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer. Sener, S.F., Imperato, J.P., Chmiel, J., Fremgen, A., Sylvester, J. CA: a cancer journal for clinicians. (1989) [Pubmed]
  13. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Topping, D.L., Clifton, P.M. Physiol. Rev. (2001) [Pubmed]
  14. The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer. Lipkin, S.M., Rozek, L.S., Rennert, G., Yang, W., Chen, P.C., Hacia, J., Hunt, N., Shin, B., Fodor, S., Kokoris, M., Greenson, J.K., Fearon, E., Lynch, H., Collins, F., Gruber, S.B. Nat. Genet. (2004) [Pubmed]
  15. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1. Ting, A.H., Jair, K.W., Suzuki, H., Yen, R.W., Baylin, S.B., Schuebel, K.E. Nat. Genet. (2004) [Pubmed]
  16. Moving beyond fluorouracil for colorectal cancer. Mayer, R.J. N. Engl. J. Med. (2000) [Pubmed]
  17. Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. Sargent, D.J., Niedzwiecki, D., O'Connell, M.J., Schilsky, R.L. N. Engl. J. Med. (2001) [Pubmed]
  18. Serum cholesterol and the risk of colorectal cancer. Holtzman, E.J., Yaari, S., Goldbourt, U. N. Engl. J. Med. (1987) [Pubmed]
  19. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. Greenberg, E.R., Baron, J.A., Tosteson, T.D., Freeman, D.H., Beck, G.J., Bond, J.H., Colacchio, T.A., Coller, J.A., Frankl, H.D., Haile, R.W. N. Engl. J. Med. (1994) [Pubmed]
  20. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. Moertel, C.G., Fleming, T.R., Creagan, E.T., Rubin, J., O'Connell, M.J., Ames, M.M. N. Engl. J. Med. (1985) [Pubmed]
  21. Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome. Vincenzi, B., Santini, D., Galluzzo, S., Russo, A., Fulfaro, F., Silletta, M., Battistoni, F., Rocci, L., Zobel, B.B., Adamo, V., Dicuonzo, G., Tonini, G. Clin. Cancer Res. (2008) [Pubmed]
  22. Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway. Vilar, E., Mukherjee, B., Kuick, R., Raskin, L., Misek, D.E., Taylor, J.M., Giordano, T.J., Hanash, S.M., Fearon, E.R., Rennert, G., Gruber, S.B. Clin. Cancer Res. (2009) [Pubmed]
  23. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Liu, B., Nicolaides, N.C., Markowitz, S., Willson, J.K., Parsons, R.E., Jen, J., Papadopolous, N., Peltomäki, P., de la Chapelle, A., Hamilton, S.R. Nat. Genet. (1995) [Pubmed]
  24. The DCC protein and prognosis in colorectal cancer. Shibata, D., Reale, M.A., Lavin, P., Silverman, M., Fearon, E.R., Steele, G., Jessup, J.M., Loda, M., Summerhayes, I.C. N. Engl. J. Med. (1996) [Pubmed]
  25. Monoallelic mutation analysis (MAMA) for identifying germline mutations. Papadopoulos, N., Leach, F.S., Kinzler, K.W., Vogelstein, B. Nat. Genet. (1995) [Pubmed]
  26. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. He, T.C., Chan, T.A., Vogelstein, B., Kinzler, K.W. Cell (1999) [Pubmed]
  27. Mutation of the ST7 tumor suppressor gene on 7q31.1 is rare in breast, ovarian and colorectal cancers. Thomas, N.A., Choong, D.Y., Jokubaitis, V.J., Neville, P.J., Campbell, I.G. Nat. Genet. (2001) [Pubmed]
  28. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Mulholland, D.J., Dedhar, S., Coetzee, G.A., Nelson, C.C. Endocr. Rev. (2005) [Pubmed]
  29. Suppression of human colorectal carcinoma cell growth by wild-type p53. Baker, S.J., Markowitz, S., Fearon, E.R., Willson, J.K., Vogelstein, B. Science (1990) [Pubmed]
  30. Identification of a chromosome 18q gene that is altered in colorectal cancers. Fearon, E.R., Cho, K.R., Nigro, J.M., Kern, S.E., Simons, J.W., Ruppert, J.M., Hamilton, S.R., Preisinger, A.C., Thomas, G., Kinzler, K.W. Science (1990) [Pubmed]
  31. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Becker, C., Fantini, M.C., Schramm, C., Lehr, H.A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., Ito, H., Nishimoto, N., Yoshizaki, K., Kishimoto, T., Galle, P.R., Blessing, M., Rose-John, S., Neurath, M.F. Immunity (2004) [Pubmed]
  32. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors. Ichiki, A.T., Quirin, Y.P., Collmann, I.R., Sonoda, T., Krauss, S. J. Natl. Cancer Inst. (1980) [Pubmed]
  33. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M.F., Taketo, M.M. Cell (1998) [Pubmed]
  34. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Liu, W., Dong, X., Mai, M., Seelan, R.S., Taniguchi, K., Krishnadath, K.K., Halling, K.C., Cunningham, J.M., Boardman, L.A., Qian, C., Christensen, E., Schmidt, S.S., Roche, P.C., Smith, D.I., Thibodeau, S.N. Nat. Genet. (2000) [Pubmed]
  35. Smad3 mutant mice develop metastatic colorectal cancer. Zhu, Y., Richardson, J.A., Parada, L.F., Graff, J.M. Cell (1998) [Pubmed]
  36. The crystal structure of DNA mismatch repair protein MutS binding to a G x T mismatch. Lamers, M.H., Perrakis, A., Enzlin, J.H., Winterwerp, H.H., de Wind, N., Sixma, T.K. Nature (2000) [Pubmed]
  37. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K.W., Vogelstein, B., Velculescu, V.E. Nature (2002) [Pubmed]
  38. Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2. Voutsadakis, I.A. J. Cell. Mol. Med. (2007) [Pubmed]
  39. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk. Skoglund, J., Song, B., Dalén, J., Dedorson, S., Edler, D., Hjern, F., Holm, J., Lenander, C., Lindforss, U., Lundqvist, N., Olivecrona, H., Olsson, L., Påhlman, L., Rutegård, J., Smedh, K., Törnqvist, A., Houlston, R.S., Lindblom, A. Clin. Cancer Res. (2007) [Pubmed]
  40. The D1822V APC polymorphism interacts with fat, calcium, and fiber intakes in modulating the risk of colorectal cancer in Portuguese persons. Guerreiro, C.S., Cravo, M.L., Brito, M., Vidal, P.M., Fidalgo, P.O., Leitão, C.N. Am. J. Clin. Nutr. (2007) [Pubmed]
  41. Vascular endothelial growth factor: basic science and clinical progress. Ferrara, N. Endocr. Rev. (2004) [Pubmed]
  42. US Preventive Services Task Force. Occult blood screening for colorectal cancer. Knight, K.K., Fielding, J.E., Battista, R.N. JAMA (1989) [Pubmed]
  43. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. Stoehlmacher, J., Park, D.J., Zhang, W., Groshen, S., Tsao-Wei, D.D., Yu, M.C., Lenz, H.J. J. Natl. Cancer Inst. (2002) [Pubmed]
  44. Expression of the MDR1 gene in human gastric and colorectal carcinomas. Mizoguchi, T., Yamada, K., Furukawa, T., Hidaka, K., Hisatsugu, T., Shimazu, H., Tsuruo, T., Sumizawa, T., Akiyama, S. J. Natl. Cancer Inst. (1990) [Pubmed]
  45. Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma. Tobi, M., Luo, F.C., Ronai, Z. J. Natl. Cancer Inst. (1994) [Pubmed]
WikiGenes - Universities